WCM
DCPH

Weld Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Weld Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,616
Closed -$262K – 1048
2019
Q2 		$262K Buy
+11,616
New +$272K 0.05% 590

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Weld Capital Management's DCPH Position: Q3 2019 in Review

Weld Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2019, closing a stake of 11,616 shares — an estimated $262K sold.

Weld Capital Management first reported a position in DCPH in Q2 2019 and held it in 1 quarter. The position peaked at $262K in Q2 2019. 122 funds tracked by Wall St. Rank hold DCPH as of Q3 2019.

  • Weld Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Weld Capital Management sold 11,616 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $262K.
  • Weld Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Weld Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $262K in Q2 2019.
  • 122 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Weld Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.